Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Trenton › NPI 1255419651
Hospital

ST. Francis Medical Center

ST. Francis Medical Center was paid $30.60M by Medicaid between Jan 2018 and Dec 2022, across 220 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.

33Billing provider infoST. FRANCIS MEDICAL CENTER
TRENTON, NJ 08629
33aNPI1255419651assigned 11/02/2006
28Total paid$30.60M
24GClaims606,123
24DCodes billed220
24AFirst – last monthJan 2018 – Dec 2022
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#47 of 93
Median peer was paid$30.60M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official KELLY, MARK controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018128,825$7.73M
2019120,677$6.83M
202082,366$3.84M
2021128,381$5.68M
2022145,874$6.52M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 22,835 20,114 $5.66M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 16,688 14,514 $4.78M
H0035 Mental health partial hospitalization, treatment, less than 24 hours 15% 16,222 1,678 $4.72M
G0378 Hospital observation service, per hour 13% 4,933 3,572 $3.92M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 9,949 8,905 $3.25M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.9% 4,637 4,411 $596K
70450 Computed tomography, head or brain; without contrast material 1.7% 4,181 3,946 $517K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.1% 2,007 1,934 $334K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.0% 12,718 3,046 $316K
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient 1.0% 3,294 1,765 $313K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.0% 443 423 $306K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 7,045 6,310 $299K
208 more codes
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 8,191 $297K
71046 Radiologic examination, chest; 2 views <1% 11,673 $252K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 16,065 $252K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 875 $234K
96375 Therapeutic injection; each additional sequential IV push <1% 8,180 $220K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,529 $202K
90863 <1% 2,979 $191K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,303 $174K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 29,316 $164K
OP272 <1% 1,938 $154K
72125 Computed tomography, cervical spine; without contrast material <1% 1,187 $144K
OP710 <1% 2,119 $132K
80053 Comprehensive metabolic panel <1% 23,132 $115K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 7,584 $114K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,512 $109K
OP370 <1% 1,877 $101K
93458 <1% 91 $93K
96361 Intravenous infusion, hydration; each additional hour <1% 9,745 $93K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 704 $84K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,193 $81K
71275 Computed tomographic angiography, chest, with contrast material <1% 382 $74K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,811 $64K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,201 $64K
99213 Doctor's office visit, returning patient (routine) <1% 2,556 $62K
84484 <1% 10,972 $60K
73130 <1% 1,322 $59K
73030 <1% 1,106 $57K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,893 $56K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,420 $54K
73630 <1% 1,234 $54K
OP250 <1% 13,280 $50K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,851 $49K
80048 Basic metabolic panel (calcium, ionized) <1% 7,492 $47K
97161 <1% 1,027 $47K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 6,013 $46K
97162 <1% 868 $45K
70486 <1% 301 $45K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 50 $43K
73564 <1% 1,380 $42K
83735 <1% 11,033 $42K
A9270 Non-covered item or service <1% 3,525 $40K
72110 <1% 414 $40K
73610 <1% 900 $38K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,650 $38K
80320 <1% 3,955 $38K
85610 <1% 13,257 $37K
85730 <1% 12,984 $37K
83880 <1% 2,607 $35K
J1644 Injection, heparin sodium, per 1000 units <1% 6,332 $33K
C1769 Guide wire <1% 737 $33K
93970 <1% 239 $32K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 769 $30K
80061 Lipid panel <1% 2,859 $27K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,188 $26K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,187 $25K
84443 Thyroid stimulating hormone (TSH) <1% 2,673 $24K
71045 Radiologic examination, chest; single view <1% 3,054 $23K
93017 <1% 97 $23K
97164 <1% 393 $22K
96367 <1% 1,085 $21K
77063 Screening digital breast tomosynthesis, bilateral <1% 419 $21K
84100 <1% 5,944 $20K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,663 $19K
96376 <1% 1,192 $18K
87040 <1% 2,409 $18K
83605 <1% 2,714 $18K
OP637 <1% 19,851 $16K
83690 <1% 7,160 $16K
76830 Ultrasound, transvaginal <1% 182 $15K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 104 $15K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 55 $15K
83036 Hemoglobin; glycosylated (A1C) <1% 2,856 $15K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,770 $14K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,129 $14K
87275 <1% 3,827 $14K
87276 <1% 3,826 $14K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,595 $14K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 469 $14K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 4,152 $13K
73110 <1% 317 $12K
87430 <1% 4,117 $12K
90715 <1% 1,314 $12K
81001 <1% 10,072 $12K
87070 <1% 4,491 $11K
73502 <1% 217 $10K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,438 $10K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 102 $10K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 494 $10K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 15 $9K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,664 $8K
81025 <1% 7,619 $8K
90686 <1% 650 $8K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,479 $8K
J2704 Injection, propofol, 10 mg <1% 2,655 $7K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 776 $7K
97116 <1% 805 $7K
93971 <1% 85 $7K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,749 $7K
OP259 <1% 6,715 $7K
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,401 $7K
J3490 Unclassified drugs <1% 47,955 $7K
88312 <1% 469 $7K
85027 <1% 1,432 $7K
83520 <1% 351 $7K
81003 <1% 5,442 $6K
82803 <1% 607 $6K
OP229 <1% 107 $5K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 14 $5K
85379 <1% 2,151 $5K
76642 <1% 29 $5K
74022 <1% 149 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,233 $5K
97165 <1% 214 $5K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,157 $4K
96368 <1% 349 $4K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 211 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 375 $4K
87186 <1% 676 $3K
C9113 Injection, pantoprazole sodium, per vial <1% 2,210 $3K
86850 <1% 496 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 382 $3K
97535 Self-care/home management training, each 15 minutes <1% 228 $3K
36415 Collection of venous blood by venipuncture <1% 1,006 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,595 $3K
82728 <1% 362 $3K
76801 <1% 53 $3K
90791 Psychiatric diagnostic evaluation <1% 43 $3K
J2060 Injection, lorazepam, 2 mg <1% 1,205 $3K
84466 <1% 386 $3K
86900 <1% 1,219 $3K
OP258 <1% 2,757 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 957 $2K
Q3014 Telehealth originating site facility fee <1% 1,590 $2K
84703 <1% 1,428 $2K
73080 <1% 54 $2K
86141 <1% 218 $2K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,998 $2K
90847 Family psychotherapy with the patient present, 50 minutes <1% 40 $2K
86901 <1% 1,219 $2K
99215 Doctor's office visit, returning patient (complex) <1% 70 $2K
90670 <1% 21 $2K
84702 <1% 472 $2K
J3411 Injection, thiamine hcl, 100 mg <1% 799 $2K
72052 <1% 25 $2K
77080 <1% 24 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 28 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,056 $2K
90750 <1% 16 $2K
73140 <1% 56 $2K
73590 <1% 40 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 28 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,142 $2K
99214 Doctor's office visit, returning patient (more involved) <1% 117 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,500 $1K
72100 <1% 29 $1K
82550 <1% 534 $1K
87420 <1% 459 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,540 $1K
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 489 $1K
90732 <1% 17 $1K
82010 <1% 333 $1K
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 726 $1K
83540 <1% 371 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,440 $1K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 70 $1K
12001 <1% 56 $1K
86803 <1% 104 $954.62
82607 <1% 160 $883.70
82009 <1% 263 $795.40
88313 <1% 80 $786.10
J0360 Injection, hydralazine hcl, up to 20 mg <1% 232 $707.53
82272 <1% 76 $707.06
0012A <1% 27 $655.65
87077 <1% 158 $590.76
87147 <1% 232 $553.29
87220 <1% 665 $516.32
80074 <1% 41 $457.50
J3480 Injection, potassium chloride, per 2 meq <1% 448 $454.69
85007 <1% 83 $442.12
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 20 $370.38
82746 <1% 80 $359.01
0011A <1% 28 $335.72
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 402 $326.91
71101 <1% 12 $290.86
29125 <1% 40 $270.99
85651 <1% 517 $266.55
J1815 Injection, insulin, per 5 units <1% 250 $229.75
J3370 Injection, vancomycin hcl, 500 mg <1% 44 $174.88
88304 <1% 13 $172.94
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 15 $127.50
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 18 $111.27
G0008 Administration of influenza virus vaccine <1% 87 $92.30
80050 General health panel <1% 21 $90.00
J1956 Injection, levofloxacin, 250 mg <1% 54 $60.51
87340 <1% 12 $43.26
87205 <1% 31 $40.61
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 13 $39.77
J1650 Injection, enoxaparin sodium, 10 mg <1% 32 $28.23
J3360 Injection, diazepam, up to 5 mg <1% 15 $24.05
J1940 Injection, furosemide, up to 20 mg <1% 56 $23.83
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 25 $18.16
85045 <1% 12 $17.00
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf <1% 14 $13.21
L4350 Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf <1% 14 $12.01
G0009 Administration of pneumococcal vaccine <1% 56 $8.18
J7050 Infusion, normal saline solution, 250 cc <1% 27 $5.62
J7510 Prednisolone oral, per 5 mg <1% 58 $3.00
J8540 Dexamethasone, oral, 0.25 mg 0% 29 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKELLY, MARK (CHIEF FINANCIAL OFFICER)
Same official

Other billing entities under KELLY, MARK

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.